Keep in touch

Tuesday 02 September 2014
Last week, several of the NC3Rs team attended the 9th World Congress on Alternatives and Animal Use in the Life Sciences, which was held in Prague, Czech Republic, from 24 to 28 August 2014. Our Communications Officer, Laura McGuinness, reports back.
Monday 07 July 2014
Last week we launched a review of our ten year collaboration with the pharmaceutical industry at an event at the House of Lords, part of our programme to mark ten years since the launch of the NC3Rs. 
Wednesday 11 June 2014
Our second NC3Rs summer school, brought together our PhD students from across the country to learn more about the 3Rs, completing a PhD, and the work of their fellow students.
Thursday 22 May 2014
This week we’ve been busy visiting York, Oxford and London to watch our researchers speaking at Pint of Science events.
Tuesday 20 May 2014
Laura McGuinness, Communications Officer at the NC3Rs, takes a look at some of the many benefits of making 3Rs research free to access. 
Wednesday 14 May 2014
Dr Mark Prescott, Head of Research Management and Policy, gives the NC3Rs position on openness in animal research.
Thursday 06 February 2014
NC3Rs Board member Dr Ian Ragan discusses new methodologies to make pluripotent stem cells and GM animals.
Thursday 09 January 2014
Researchers from Queen Mary University have this week published research showing that the NC3Rs ARRIVE guidelines, whilst being adopted and endorsed by over 300 journals, are not being adequately implemented. Dr Katie Lidster, co-author of the article* discusses the research and its implications.
Thursday 12 December 2013
This month The Scientist magazine announced the winners of their annual Top 10 Innovations 2013 competition, which highlights the best global technologies to enter the lab. Three of these have potential to replace, reduce or refine the use of animals in research. The NC3Rs Technology Programme Manager, Dr...
Wednesday 27 November 2013
Professor David Baker, Queen Mary University of London, explains how a novel animal model developed with NC3Rs funding offers a significant refinement improvement over previous animal models of autoimmunity, describing how it can be used to discover new treatments for people with MS.